Back
Perspective Therapeutics Quote, Financials, Valuation and Earnings
Buy these stocks BEFORE President Trump returns to the Oval Office
See details on which stocks are poised to surge.
Sell
30
CATX
Perspective Therapeutics
Last Price:
7.88
Seasonality Move:
40.67%
7 Day Trial
ALL ACCESS PASS
$
7
Trump's IRS Hands Massive 'Victory Gift' To 401K Owners
Shield your IRA, 401(k) and pension savings from this coming anti-Trump backlash.Perspective Therapeutics Price Quote
$7.88
Perspective Therapeutics Key Stats
Sell
30
Perspective Therapeutics (CATX)
is a Sell
Day range:
$7.87 - $8.93
52-week range:
$2.28 - $19.05
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
1.56%
Volume:
1.8M
Avg. volume:
881.9K
1-year change:
212.95%
Market cap:
$531.3M
Revenue:
$0
EPS:
$-1.68
How Much Does Perspective Therapeutics Make?
Data Unavailable
Is Perspective Therapeutics Growing As A Company?
Data Unavailable
Perspective Therapeutics Stock Price Performance
-
Did Perspective Therapeutics Stock Go Up Last Month?
Perspective Therapeutics share price went down by -37.26% last month -
Did CATX's Share Price Rise Over The Last Year?
CATX share price rose by 212.95% over the past 1 year
What Is Perspective Therapeutics 52-Week High & Low?
-
What Is Perspective Therapeutics’s 52-Week High Share Price?
Perspective Therapeutics has traded as high as $19.05 over the past 52 weeks -
What Is Perspective Therapeutics’s 52-Week Low Share Price?
Perspective Therapeutics has traded as low as $2.28 over the past 52 weeks
Perspective Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Perspective Therapeutics?
-
How Much Debt Does Perspective Therapeutics Have?
Total long term debt quarterly is $0 -
How Much Cash Does Perspective Therapeutics Have?
Cash and short term investments quarterly total is $292.9M -
What Is Perspective Therapeutics’s Book Value Per Share?
Book value per share is 5.06
Is Perspective Therapeutics Cash Flow Positive?
-
What Is CATX Cash Flow From Operations?
Cash flow from operations (TTM) is -$14.2M -
What Is Perspective Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $288.8M -
What Is Perspective Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$50.9M
Perspective Therapeutics Return On Invested Capital
Data Unavailable
Perspective Therapeutics Earnings Date & Stock Price
-
What Is Perspective Therapeutics's Stock Price Today?
A single share of CATX can be purchased today for 7.88 -
What Is Perspective Therapeutics’s Stock Symbol?
Perspective Therapeutics trades on the nyam under the ticker symbol: CATX -
When Is Perspective Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Perspective Therapeutics is scheduled on March 28, 2025 -
When Is CATX's next ex-dividend date?
Perspective Therapeutics's next ex-dividend date is November 17, 2024 -
How To Buy Perspective Therapeutics Stock?
You can buy Perspective Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Perspective Therapeutics Competitors
-
Who Are Perspective Therapeutics's Competitors?
Below is a list of companies who compete with Perspective Therapeutics or are related in some way:
Perspective Therapeutics Dividend Yield
-
What Is CATX Dividend Yield?
Perspective Therapeutics’s dividend yield currently is 0% -
What Is Perspective Therapeutics’s Payout Ratio?
Perspective Therapeutics’s payout ratio is 0% -
When Did Perspective Therapeutics Last Pay A Dividend?
The latest dividend pay date is November 17, 2024 -
What Is Perspective Therapeutics’s Dividend Per Share?
Perspective Therapeutics pays a dividend of $0.00 per share
Perspective Therapeutics Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 0.31% |
| Revenue: | 0% | 55.1% |
Analyst Recommendations
| Buy Recommendations: | 9 |
|---|---|
| Hold Recommendations: | 0 |
| Sell Recommendations: | 0 |
| Price Target: | 21.35 |
| Upside from Last Price: | 170.94% |